These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21553140)

  • 1. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.
    Kitano M; Rahbari R; Patterson EE; Xiong Y; Prasad NB; Wang Y; Zeiger MA; Kebebew E
    Ann Surg Oncol; 2011 Nov; 18(12):3443-52. PubMed ID: 21553140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
    Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
    Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.
    Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E
    Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
    Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
    Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
    BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.
    Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
    Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
    Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed microRNA in parathyroid tumors.
    Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
    Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
    Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
    Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.
    Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F
    Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.